BACKGROUND: Recommendations on eligibility criteria for donation of haematopoietic stem cells, management of collection of the cells and follow-up mainly concern unrelated donors. The aim of this study was to analyse the screening of related donors and collection practices at different Italian apheresis centres. MATERIALS AND METHODS: A questionnaire regarding eligibility criteria for related haematopoietic stem cell donors, their peripheral blood collections and early follow-up was sent to several apheresis units. Data from the full charts of 500 candidates, screened between May 2005 and December 2009, were retrospectively evaluated. RESULTS: The donors' records, eligibility criteria, collections and follow-up are managed differently in each centre. Of the 500 evaluable candidates (51.2% male, 49.8% female; median age 47 years, range 13-77), 26.4% underwent thorough screening according to Italian Bone Marrow Donor Registry standards, while local protocols were applied to 73.6%; 91 candidates (18.2%) proved ineligible for donation. In the end, 352 donors (53.4% male, 46.6% female; median age 45 years, range 16-76) underwent 508 leukaphereses. Central venous catheters were used in 8.0% of donors, mainly in one centre. Unsuitable pre-apheresis peripheral blood parameters were reported in 38.7% of the aphereses. Leukapheresis-related adverse events were recorded in 23.0% of the procedures, with a drop-out rate of 0.2% for severe events. No donation-related fatalities occurred. The CD34+ cell yield was <2×10(6)/kg of recipient's body weight from 1.1% of donors ≥70 years old. DISCUSSION: More uniformity in donor screening procedures, management of peripheral blood collection and follow-up should be planned at a national level to maximise the safety of related donors.
BACKGROUND: Recommendations on eligibility criteria for donation of haematopoietic stem cells, management of collection of the cells and follow-up mainly concern unrelated donors. The aim of this study was to analyse the screening of related donors and collection practices at different Italian apheresis centres. MATERIALS AND METHODS: A questionnaire regarding eligibility criteria for related haematopoietic stem cell donors, their peripheral blood collections and early follow-up was sent to several apheresis units. Data from the full charts of 500 candidates, screened between May 2005 and December 2009, were retrospectively evaluated. RESULTS: The donors' records, eligibility criteria, collections and follow-up are managed differently in each centre. Of the 500 evaluable candidates (51.2% male, 49.8% female; median age 47 years, range 13-77), 26.4% underwent thorough screening according to Italian Bone Marrow Donor Registry standards, while local protocols were applied to 73.6%; 91 candidates (18.2%) proved ineligible for donation. In the end, 352 donors (53.4% male, 46.6% female; median age 45 years, range 16-76) underwent 508 leukaphereses. Central venous catheters were used in 8.0% of donors, mainly in one centre. Unsuitable pre-apheresis peripheral blood parameters were reported in 38.7% of the aphereses. Leukapheresis-related adverse events were recorded in 23.0% of the procedures, with a drop-out rate of 0.2% for severe events. No donation-related fatalities occurred. The CD34+ cell yield was <2×10(6)/kg of recipient's body weight from 1.1% of donors ≥70 years old. DISCUSSION: More uniformity in donor screening procedures, management of peripheral blood collection and follow-up should be planned at a national level to maximise the safety of related donors.
Authors: P Anderlini; M Donato; K W Chan; Y O Huh; A P Gee; M J Lauppe; R E Champlin; M Körbling Journal: Transfusion Date: 1999-06 Impact factor: 3.157
Authors: D Niederwieser; C Gentilini; U Hegenbart; T Lange; P Moosmann; W Pönisch; H Al-Ali; M Raida; P Ljungman; A Tyndall; A Urbano-Ispizua; H M Lazarus; A Gratwohl Journal: Bone Marrow Transplant Date: 2004-10 Impact factor: 5.483
Authors: C Tassi; P L Tazzari; F Bonifazi; V Giudice; A Nannetti; F Ricci; S Rizzi; G Bandini; R Conte Journal: Bone Marrow Transplant Date: 2005-08 Impact factor: 5.483
Authors: Jeffrey McCullough; Jeffrey Kahn; John Adamson; Paolo Anderlini; Richard Benjamin; Dennis Confer; Mary Eapen; Betsy Hirsch; David Kuter; Ellen Lazarus; Derwood Pamphilon; David Stroncek; Jeremy Sugarman; Robert Wilson Journal: Transfusion Date: 2008-06-28 Impact factor: 3.157
Authors: Javier de la Rubia; Felipe de Arriba; Cristina Arbona; María J Pascual; Concha Zamora; Andrés Insunza; Dorleta Martínez; Carmen Paniagua; Miguel A Díaz; Miguel A Sanz Journal: Haematologica Date: 2008-04-02 Impact factor: 9.941
Authors: N Sacchi; P Costeas; L Hartwell; C K Hurley; C Raffoux; A Rosenmayr; H Greinix Journal: Bone Marrow Transplant Date: 2008-03-24 Impact factor: 5.483
Authors: S Bräuninger; K Thorausch; B Luxembourg; M Schulz; K U Chow; E Seifried; H Bonig Journal: Bone Marrow Transplant Date: 2014-08-04 Impact factor: 5.483
Authors: C Anthias; S M van Walraven; B S Sørensen; G N de Faveri; M Fechter; J Cornish; A Bacigalupo; C Müller; M Boo; B E Shaw Journal: Bone Marrow Transplant Date: 2015-03-02 Impact factor: 5.483
Authors: Chloe Anthias; Paul V O'Donnell; Deidre M Kiefer; Jean Yared; Maxim Norkin; Paolo Anderlini; Bipin N Savani; Miguel A Diaz; Menachem Bitan; Joerg P Halter; Brent R Logan; Galen E Switzer; Michael A Pulsipher; Dennis L Confer; Bronwen E Shaw Journal: Biol Blood Marrow Transplant Date: 2015-11-18 Impact factor: 5.742
Authors: Chloe Anthias; Bronwen E Shaw; Deidre M Kiefer; Jane L Liesveld; Jean Yared; Rammurti T Kamble; Anita D'Souza; Peiman Hematti; Matthew D Seftel; Maxim Norkin; Zachariah DeFilipp; Kimberly A Kasow; Muneer H Abidi; Bipin N Savani; Nirali N Shah; Paolo Anderlini; Miguel A Diaz; Adriana K Malone; Joerg P Halter; Hillard M Lazarus; Brent R Logan; Galen E Switzer; Michael A Pulsipher; Dennis L Confer; Paul V O'Donnell Journal: Biol Blood Marrow Transplant Date: 2015-11-18 Impact factor: 5.742